|
Portfolio Company News, 2010
- December 20
-
METABOLON IDENTIFIES ADENOSINE-MEDIATED SICKLING IN SICKLE CELL DISEASE AND ASSOCIATED END ORGAN DAMAGE
- December 8
-
Digitalsmiths named in the top 50 finalists of the Technology 500
- December 7
-
Centice Corporation and Pharmacists Mutual® Insurance Company Team to Offer Discounts Centice Corporation and Pharmacists Mutual® Insurance Company Team to Offer Discounts
- December 2
-
Centice Corporation awarded nearly $500,000 in qualified investment rebates from the IRS
- December 1
-
Digitalsmiths Acquisition Fills Out Metadata Portfolio
- November 30
-
METABOLOMICS TECHNOLOGY APPLIED TO DIABETES RESEARCH
- November 30
-
Argos Therapeutics Initiates Dosing of Patients in Phase 2b Clinical Trial of Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients
- November 16
-
Centice Corporation Finalizes Advisory Board of Leading Pharmacy Experts
- November 15
-
Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and part of the REG2 Anticoagulant System, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
- November 2
-
Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada
- October 13
-
METABOLON EXTENDS BIOCHEMICAL UNDERSTANDING OF ALZHEIMERS DISEASE
- September 22
-
METABOLON AND COLGATE IDENTIFY EARLY BIOMARKERS IN PERIODONTAL DISEASE
- August 2
-
Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients
- July 27
-
Therapeutic HIV vaccines show promise
- July 26
-
Regado Biosciences Announces Publication in the American Heart Association Journal Circulation of the results of a Phase 2a Study for the REG1 Anticoagulant System in Elective Percutaneous Interventions
- July 19
-
Data for Personalized Dendritic Cell-Based Immunotherapy Presented in Two Posters and an oral presentation at the International AIDS Conference
- July 13
-
"Research Advances from Therapeutic HIV Vaccines and Other Immune-Based Therapies" to be Showcased at NAPWA Sponsored Community Treatment Research Forum at XVIII World AIDS Conference
- July 2
-
METABOLON IDENTIFIES PRETERM LABOR BIOMARKERS
- June 16
-
HyperBranch wins CE mark for Adherus spinal sealant
- May 26
-
REGADO BIOSCIENCES, INC. CONTINUES TO EXPAND ITS PATENT PORTFOLIO BY ANNOUNCING ISSUANCE OF A NEW PATENT FOR ITS PRODUCT CANDIDATES, THE REG1 AND REG2 ANTICOAGULATION SYSTEMS
- May 21
-
Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
- May 17
-
Argos Therapeutics Presents Phase 2a Data for Arcelis HIV Program Demonstrating Positive Impact on Viral Diversity and Viral Load
- May 13
-
METABOLON RELEASES POTENTIAL NONINVASIVE BIOMARKERS IDENTIFIED IN NASH STUDY
- February 5
-
Regado seeking solution to clotting conundrum
- January 13
-
PATENT AWARDED TO METABOLON FOR METABOLOMICS METHOD
|